ANAB
Price
$22.53
Change
-$1.16 (-4.90%)
Updated
Aug 6, 04:59 PM (EDT)
Capitalization
696.02M
5 days until earnings call
HRMY
Price
$34.67
Change
-$0.27 (-0.77%)
Updated
Aug 6, 04:59 PM (EDT)
Capitalization
2.01B
90 days until earnings call
Interact to see
Advertisement

ANAB vs HRMY

Header iconANAB vs HRMY Comparison
Open Charts ANAB vs HRMYBanner chart's image
AnaptysBio
Price$22.53
Change-$1.16 (-4.90%)
Volume$23.42K
Capitalization696.02M
Harmony Biosciences Holdings
Price$34.67
Change-$0.27 (-0.77%)
Volume$17.34K
Capitalization2.01B
ANAB vs HRMY Comparison Chart in %
Loading...
ANAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HRMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANAB vs. HRMY commentary
Aug 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANAB is a Hold and HRMY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 06, 2025
Stock price -- (ANAB: $23.69 vs. HRMY: $34.94)
Brand notoriety: ANAB and HRMY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANAB: 67% vs. HRMY: 206%
Market capitalization -- ANAB: $696.02M vs. HRMY: $2.01B
ANAB [@Biotechnology] is valued at $696.02M. HRMY’s [@Biotechnology] market capitalization is $2.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $215.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANAB’s FA Score shows that 0 FA rating(s) are green whileHRMY’s FA Score has 0 green FA rating(s).

  • ANAB’s FA Score: 0 green, 5 red.
  • HRMY’s FA Score: 0 green, 5 red.
According to our system of comparison, HRMY is a better buy in the long-term than ANAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANAB’s TA Score shows that 5 TA indicator(s) are bullish while HRMY’s TA Score has 6 bullish TA indicator(s).

  • ANAB’s TA Score: 5 bullish, 5 bearish.
  • HRMY’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, HRMY is a better buy in the short-term than ANAB.

Price Growth

ANAB (@Biotechnology) experienced а -9.65% price change this week, while HRMY (@Biotechnology) price change was -1.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.67%. For the same industry, the average monthly price growth was +14.79%, and the average quarterly price growth was +13.41%.

Reported Earning Dates

ANAB is expected to report earnings on Nov 11, 2025.

HRMY is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Biotechnology (-0.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HRMY($2.01B) has a higher market cap than ANAB($696M). ANAB YTD gains are higher at: 78.927 vs. HRMY (1.540). HRMY has higher annual earnings (EBITDA): 238M vs. ANAB (-76.35M). HRMY has more cash in the bank: 507M vs. ANAB (340M). ANAB has less debt than HRMY: ANAB (15.6M) vs HRMY (176M). HRMY has higher revenues than ANAB: HRMY (745M) vs ANAB (112M).
ANABHRMYANAB / HRMY
Capitalization696M2.01B35%
EBITDA-76.35M238M-32%
Gain YTD78.9271.5405,124%
P/E RatioN/A13.56-
Revenue112M745M15%
Total Cash340M507M67%
Total Debt15.6M176M9%
FUNDAMENTALS RATINGS
ANAB: Fundamental Ratings
ANAB
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
94
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
78
SEASONALITY SCORE
1..100
33

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANABHRMY
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 15 days ago
78%
Bullish Trend 15 days ago
75%
Declines
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 6 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
ANAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HRMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CPCCX4.03N/A
N/A
Comstock Capital Value C
VGENX48.30N/A
N/A
Vanguard Energy Inv
BUFEX59.18N/A
N/A
Buffalo Blue Chip Growth
GLCCX21.92N/A
N/A
Goldman Sachs Large Cap Gr Insghts C
GMLGX34.61N/A
N/A
GuideMark® Large Cap Core Service